These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 24830933

  • 1. Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C.
    Li Z, Zhang Y, An J, Feng Y, Deng H, Xiao S, Ji F.
    J Clin Virol; 2014 Jul; 60(3):190-5. PubMed ID: 24830933
    [Abstract] [Full Text] [Related]

  • 2. A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C.
    Tavakoli-Tabasi S, Bagree A.
    J Clin Gastroenterol; 2012 Feb; 46(2):162-7. PubMed ID: 21814144
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon-alpha and ribavirin.
    Striki A, Manolakopoulos S, Deutsch M, Mela M, Kalafateli M, Schini M, Anagnostou O, Triantos C, Andreadis I, Ketikoglou I, Papatheodoridis G, Pectasides D.
    J Viral Hepat; 2014 Feb; 21(9):624-32. PubMed ID: 24224747
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C.
    Tseng CW, Chang TT, Tzeng SJ, Hsieh YH, Hung TH, Huang HT, Wu SF, Tseng KC.
    Clin Interv Aging; 2016 Feb; 11():327-34. PubMed ID: 27051280
    [Abstract] [Full Text] [Related]

  • 7. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R, Planas Vilà R, Durández Lazaro R, Fábregas Puigtió S.
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [Abstract] [Full Text] [Related]

  • 8. Adverse effects of peg-Interferon and Ribavirin combined antiviral treatment in a Romanian hepatitis C virus infected cohort.
    Predescu O, Streba LA, Irimia E, Streba L, Mogoantă L.
    Rom J Morphol Embryol; 2012 Oct; 53(3):497-502. PubMed ID: 23010773
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
    Enjoji M, Dainichi T, Gondo H, Urabe K.
    Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
    [Abstract] [Full Text] [Related]

  • 11. [Cutaneous adverse events of telaprevir/peginterferon/ribavirin therapy for chronic hepatitis C: A multicenter prospective cohort study].
    Lorcy S, Gaudy-Marqueste C, Botta D, Portal I, Quiles N, Oulies V, Mancini J, Grob JJ, Richard MA.
    Ann Dermatol Venereol; 2016 May; 143(5):336-46. PubMed ID: 27161648
    [Abstract] [Full Text] [Related]

  • 12. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus.
    Hashimoto Y, Kanto H, Itoh M.
    J Dermatol; 2007 Aug; 34(8):577-82. PubMed ID: 17683392
    [Abstract] [Full Text] [Related]

  • 13. Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C.
    Gaeta GB, Precone DF, Felaco FM, Bruno R, Spadaro A, Stornaiuolo G, Stanzione M, Ascione T, De Sena R, Campanone A, Filice G, Piccinino F.
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1633-9. PubMed ID: 12197842
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment.
    Masip M, Tuneu L, Pagès N, Torras X, Gallego A, Guardiola JM, Faus MJ, Mangues MA.
    Int J Clin Pharm; 2015 Dec; 37(6):1143-51. PubMed ID: 26267215
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative efficacy of combined treatment with intron A and pegintron in combination with ribavirin of patients with chronic hepatitis C].
    Gromova NI, Bogomolov BP.
    Ter Arkh; 2004 Dec; 76(2):31-5. PubMed ID: 15106411
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Face skin hyperpigmentation during pegylated interferon and ribavirin therapy.
    Yaşar B, Yaşar Ş, Güneş P.
    Turk J Gastroenterol; 2015 Mar; 26(2):189-90. PubMed ID: 25835121
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.